⚖UPC-Intel
🇪🇺 UPC

UPC_CFI_29/2026

Court
Brussels Local Division
Type of action
infringement
Patent
CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN
Language
en
Claimant / applicant
  • 2seventy bio, Inc.
Defendant / respondent
  • Johnson & Johnson
  • Janssen Pharmaceuticals Inc.
  • Janssen Pharmaceutica NV
  • Janssen Biologics B.V.
  • Janssen-Cilag GmbH
  • Janssen-Cilag A/S
  • Janssen-Cilag Farmaceutica Lda.
  • Janssen-Cilag International NV
  • Janssen Biotech, Inc.
  • Janssen-Cilag
  • Janssen-Cilag NV
  • Legend Biotech Corporation
  • Janssen-Cilag B.V.
  • LEGEND BIOTECH USA INC.
  • LEGEND BIOTECH IRELAND LIMITED; AND
  • LEGEND BIOTECH BELGIUM BV
  • Janssen-Cilag SpA
  • Janssen-Cilag Aktiebolag

Track this case

Get an email when a new order or decision is published in UPC_CFI_29/2026.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.